VoxNeuro sits in the objective cognitive assessment segment, using ERP-derived EEG biomarkers as an adjunct to behavioral neuropsychological testing. Its position is clinically oriented, with regulatory status in Canada and the US and a software-led model built around standard EEG acquisition.